These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

51 related articles for article (PubMed ID: 12898206)

  • 1. Why rankings of biomedical image analysis competitions should be interpreted with care.
    Maier-Hein L; Eisenmann M; Reinke A; Onogur S; Stankovic M; Scholz P; Arbel T; Bogunovic H; Bradley AP; Carass A; Feldmann C; Frangi AF; Full PM; van Ginneken B; Hanbury A; Honauer K; Kozubek M; Landman BA; März K; Maier O; Maier-Hein K; Menze BH; Müller H; Neher PF; Niessen W; Rajpoot N; Sharp GC; Sirinukunwattana K; Speidel S; Stock C; Stoyanov D; Taha AA; van der Sommen F; Wang CW; Weber MA; Zheng G; Jannin P; Kopp-Schneider A
    Nat Commun; 2018 Dec; 9(1):5217. PubMed ID: 30523263
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combining Technology with Quality in Medical Care.
    Abreu LM
    Arq Bras Cardiol; 2024; 121(2):e20240127. PubMed ID: 38695405
    [No Abstract]   [Full Text] [Related]  

  • 3. PET with Different Radiopharmaceuticals in Neuroendocrine Neoplasms: An Umbrella Review of Published Meta-Analyses.
    Treglia G; Sadeghi R; Giovinazzo F; Galiandro F; Annunziata S; Muoio B; Kroiss AS
    Cancers (Basel); 2021 Oct; 13(20):. PubMed ID: 34680321
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic Performance of PET or PET/CT with Different Radiotracers in Patients with Suspicious Lung Cancer or Pleural Tumours according to Published Meta-Analyses.
    Lococo F; Muoio B; Chiappetta M; Nachira D; Petracca Ciavarella L; Margaritora S; Treglia G
    Contrast Media Mol Imaging; 2020; 2020():5282698. PubMed ID: 32405280
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biosimilars: evidential standards for health technology assessment.
    Hughes DA
    Clin Pharmacol Ther; 2010 Mar; 87(3):257-61. PubMed ID: 20160743
    [No Abstract]   [Full Text] [Related]  

  • 6. Using health technology assessment to identify gaps in evidence and inform study design for comparative effectiveness research.
    Tunis SR; Turkelson C
    J Clin Oncol; 2012 Dec; 30(34):4256-61. PubMed ID: 23071248
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The need for Health Technology Assessments of PET.
    Van Tinteren H; Hoekstra OS; Boers M
    Eur J Nucl Med Mol Imaging; 2003 Oct; 30(10):1438-9; author reply 1439. PubMed ID: 12898206
    [No Abstract]   [Full Text] [Related]  

  • 8. Health technology assessment of PET in oncology: re Eur J Nucl Med Mol Imaging 2003; 30:637-641.
    Kristensen FB; Adams E; Briones E; Coburn D; Facey K; Hansen NW; Hoeksema J; Mørland B
    Eur J Nucl Med Mol Imaging; 2004 Feb; 31(2):295-7; author reply 297-8; discussion 298. PubMed ID: 15129712
    [No Abstract]   [Full Text] [Related]  

  • 9. The need for independent physics advice.
    Bergmann H
    Eur J Nucl Med Mol Imaging; 2003 Apr; 30(4):491-3. PubMed ID: 12785357
    [No Abstract]   [Full Text] [Related]  

  • 10. Perspectives on "early dialogue" between a manufacturer and health technology assessment agencies.
    Geisler BP
    Value Health; 2011 Jun; 14(4):607. PubMed ID: 21669386
    [No Abstract]   [Full Text] [Related]  

  • 11. Is PET the future of nuclear medicine?
    Maisey M
    Eur J Nucl Med Mol Imaging; 2003 Jul; 30(7):1045-6. PubMed ID: 12827314
    [No Abstract]   [Full Text] [Related]  

  • 12. Are health technology assessments a reliable tool in th analysis of the clinical value of PET in oncology? Who audits the auditors?
    Højgaard L
    Eur J Nucl Med Mol Imaging; 2003 May; 30(5):637-41. PubMed ID: 12838956
    [No Abstract]   [Full Text] [Related]  

  • 13. Effectiveness of positron emission tomography in the preoperative assessment of patients with suspected non-small-cell lung cancer: the PLUS multicentre randomised trial.
    van Tinteren H; Hoekstra OS; Smit EF; van den Bergh JH; Schreurs AJ; Stallaert RA; van Velthoven PC; Comans EF; Diepenhorst FW; Verboom P; van Mourik JC; Postmus PE; Boers M; Teule GJ
    Lancet; 2002 Apr; 359(9315):1388-93. PubMed ID: 11978336
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Magnetic resonance coronary angiography--assessing an emerging technology.
    Steinberg EP
    N Engl J Med; 1993 Mar; 328(12):879-80. PubMed ID: 8441432
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.